Tumor Ablation Market is Anticipated to Reach US$ XX Bn by 2025, Due to High Prevalance of Cancer across the Globe

08/feb/2019 10:27:16 sai krishna Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Tumor Ablation Market is Anticipated to Reach US$ XX Bn by 2025, Due to High Prevalance of Cancer across the Globe



The Tumor Ablation Market is anticipated to reach about US$ XX Bn by 2025, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” owing to a high prevalence of cancer across the globe.


Precision Business Insights (PBI) in its report titled “Tumor Ablation Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.


The tumor ablation market size was accounted for US$ XX Bn in 2018 and anticipated to account for US$ XX Bn by 2025. Increasing demand for minimally invasive surgeries coupled with technological advancements in thermal ablation is anticipated to boost market growth. In addition, rising per capita income is enabling people to opt for advanced treatment for tumors. This factor is anticipated to positively influence market growth over the forecast period. Active role of healthcare agencies and government in creating awareness about various cancer types is expected to facilitate usage of tumor ablation therapy. However, stringent regulatory framework, prolonged time of approvals for product launching and cost associated with it are expected to hamper the growth of tumor ablation market.



Sample: https://precisionbusinessinsights.com/request-sample?product_id=17161


Tumor ablation market segmented on the basis of function, technology, application, end user and Geographical regions.


Radiofrequency Ablation Segment Expected to Dominate the Market


On the basis of technology, the global tumor ablation market can be segmented as cryoablation, radiofrequency ablation, microwave ablation and others. The radiofrequency ablation dominates the global tumor ablation market in terms of market size, due to its specification of treating target tissues without causing significant damage to the surrounding healthy cells. Whereas, microwave ablation technology is expected to grow at the fastest rate in the coming years, due to increasing private funding and increasing adoption of microwave tumor ablation among healthcare professionals.


Liver Cancer Projected to Dominate the Revenue Share.


On the basis of application, the tumor ablation market can be categorized as liver cancer, lung cancer, bone metastasis and kidney cancer. Liver cancer leads the global tumor ablation market in terms of market size; whereas, lung cancer is expected to grow with the fastest rate in the forecasted period, due to growing number of lung cancer cases, up surging level of alcohol and cigarette abuse, and increasing private investment to develop innovative lung cancer ablation products.


North America, Accounts for Major Revenue Share for Tumor Ablation Market


Precision Business Insights (PBI) tumor ablation market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America is likely to dominate the global tumor ablation market in the coming years, due to high adoption of tumor ablation products and increasing demand for minimally invasive surgeries. Asia-Pacific is the fastest growing region in the global tumor ablation market, due to presence of huge pool of patients, intensifying government support, and increasing prevalence of cancer in the region. In addition, the tumor ablation Asia-Pacific market is growing, due to increasing healthcare expenditure and refining healthcare infrastructure in the emerging countries, such as India and China.


Request methodology:




New Product Launch Play Vital Role in Tumor Ablation Market


Some of the key players are actively participating in various market strategy to create a strong consumer base and outreach the global market. For instance, February 2015: SonaCare Medical LLC launched Sonalink-a remote patient monitoring platform-that can be used during HIFU procedures.

Key player’s profiles in the report are Mermaid Medical A/S, Medtronic PLC, Boston Scientific Corporation, HealthTronics Inc., CONMED Corporation, EDAP TMS S.A., AngioDynamics Inc., Galil Medical Inc., Misonix Inc., Neuwave Medical Inc., Smith & Nephew PLC and Sonacare Medical LLC., among others.


Detailed Segmentation


By Function Type


o   Automated/Robotic ablation

o   Conventional ablation devices


By Technology Type


o   Hyperthermic ablation

o   Radiofrequency ablation

o   Microwave ablation

o   Laser ablation

o   Ultrasound ablation

o   Cryoablation


By Application Type


o   Primary lung cancer

o   Metastatic diseases

o   Pain palliation


By End-user Type


o   Hospitals

o   Oncology institutes

o   Diagnostic centres




o   North America

§  U.S.

§  Canada

o   Europe

§  Germany

§  UK

§  France

§  Russia

§  Spain

§  Italy

§  Rest of Europe

o   Asia-Pacific

§  China

§  Japan

§  India


§  Rest of Asia Pacific

o   Latin America

§  Brazil

§  Mexico

§  Argentina

§  Chile

§  Rest of Latin America

o   Middle East and Africa

§  South Africa

§  GCC

§  Rest of MEA




Full story: https://precisionbusinessinsights.com/market-reports/global-tumor-ablation-market/



blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl